BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  Fortrea Reports Fourth Quarter and Full-Year 2024 Results; Issues Full-Year 2025 Guidance

  March 4, 2025

   · 

  19 min read
• Press Releases

  Syndax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

  March 4, 2025

   · 

  17 min read
• Press Releases

  Immunocore to present at upcoming March 2025 investor conferences

  March 4, 2025

   · 

  1 min read
• Press Releases

  PolyPid to Participate in the 37th Annual ROTH Conference

  March 4, 2025

   · 

  1 min read
• Press Releases

  Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2024 Results and Business Highlights

  March 4, 2025

   · 

  22 min read
• Press Releases

  Rapport Therapeutics Announces Appointment of Dr. Jeffrey Sevigny as Chief Medical Officer to Drive Clinical Strategy and Precision Medicine Development

  March 4, 2025

   · 

  7 min read
• Press Releases

  BrightSpec Launches World’s First Commercial MRR Instruments in 50 Years at PittCon 2025

  March 4, 2025

   · 

  3 min read
• Press Releases

  Marengo Therapeutics Announces Second Drug Candidate Nomination from Strategic Collaboration with Ipsen

  March 4, 2025

   · 

  2 min read
• Press Releases

  QALSODY™ (tofersen injection) Receives Conditional Marketing Authorization from Health Canada as the First ALS Treatment Targeting a Genetic Cause

  March 4, 2025

   · 

  7 min read
• Press Releases

  BioLife Solutions Reports Fourth Quarter and Full Year 2024 Financial Results

  March 4, 2025

   · 

  17 min read